Advertisement

Department of State Health Services to distribute anti-viral drug in Laredo

File photo: Texas Governor Greg Abbott
File photo: Texas Governor Greg Abbott(KGNS)
Published: May. 20, 2020 at 11:01 AM CDT
Email this link
Share on Pinterest
Share on LinkedIn

Texas Governor Greg Abbott announced that the Texas Department of State Health Services (DSHS) is distributing two cases of the antiviral drug remdesivir to two hospitals in Laredo.

These cases have been provided to DSHS through the U.S. Department of Health and Human Services. Last week, DSHS sent an initial 30 cases of remdesivir it received from the federal government to 15 hospitals throughout the State of Texas.

Abbott says the state has been working to ensure hospitals and medical providers have the necessary resources they need to treat and diagnose patients with COVID-19.

The governor went on to thank those with the U.S. Department of Health and Human Services for sending the cases of remdesivir to the state of Texas.

Remdesivir has shown promise in early trials in speeding up the recovery time among hospitalized COVID-19 patients. To ensure the medication can quickly be used for patients across the state, the distribution is based on the number of patients in the hospital and in intensive care in each hospital region. Within those regions, allocations are based on the number of intensive care beds by hospital.

DSHS has consulted on the remdesivir distribution rationale with the Texas Hospital Association, Texas Medical Association, and the Rapid Assessment Subcommittee of the Texas Task Force on Infectious Disease Preparedness and Response.

Medical staff at each hospital will determine how the drug will be used, though it must be prescribed in accordance with the Food and Drug Administration’s Emergency Use Authorization, allowing for the treatment of suspected or confirmed COVID-19 in adults and children hospitalized with severe diseases, such as those in intensive care. Preliminary results from a clinical trial showed the average recovery time among patients who received remdesivir was 11 days versus 15 days with a placebo.

The supply is part of a donation from drug maker Gilead.

Latest News

Latest News